Owners, management and financials
CVR: 19995607
Previous names: PBH 25.376 ApS
DKK 1,434,475
Gross profit
Net result: DKK 974,825
LEV-VEL ApS (50-66,65%), NLDB Holding ApS (50-66,65%)
CVR · view owners
Malene Dybdahl Birch
CVR · view management
Active
Founded 1 April 1997
CVR · view overview
0 employees
CVR · 2000
Director role ended: Ole Birch
CVR · 27/06/2024
View the full event history
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2026, the company reported a gross profit of DKK 1,434,475 and a net result of DKK 974,825. Equity in the 2026 report amounted to DKK 1,100,859.
Source: annual report 2026, Danish Business Authority
OBA-PHARMA ApS demonstrates a strong financial health characterized by consistent profitability and a solid gross profit margin. Over the past five years, gross profit has shown an upward trend, increasing from 1,041,316 DKK in 2022 to 3,402,201 DKK in 2024, while profit surged from 752,443 DKK to 2,670,973 DKK during the same period. The company's equity has fluctuated but remains relatively stable, standing at 1,100,859 DKK in 2026, indicating a healthy capital position. However, the absence of disclosed revenue figures raises concerns about transparency and overall market position within the pharmaceutical distribution sector.
AI-generated summary · Generated 06/10/2026
Selskabets formål er handel og investering og dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/07/2025 – 30/06/2026 | 1.4M | 975K | 6.5M | 1.1M | 0 | |
| 202401/10/2023 – 30/09/2024 | 3.4M | 2.7M | 5.9M | 674K | 0 | |
| 202301/10/2022 – 30/09/2023 | 2.9M | 2.1M | 11.6M | 2.2M | 0 | |
| 202201/10/2021 – 30/09/2022 | 1M | 752K | 6.6M | 1.9M | 0 | |
| 202101/10/2020 – 30/09/2021 | 1.3M | 1M | 4.9M | 2.2M | 0 | |
| 202001/10/2019 – 30/09/2020 | 1.1M | 865K | 3.2M | 1.2M | 0 | |
| 201901/10/2018 – 30/09/2019 | 2.3M | 1.8M | 4.5M | 2.3M | - | |
| 201801/10/2017 – 30/09/2018 | 2.5M | 2.1M | 8.8M | 6.5M | - | |
| 201701/10/2016 – 30/09/2017 | 2.8M | 2.2M | 6.7M | 4.4M | - | |
| 201601/10/2015 – 30/09/2016 | 2.8M | 2.2M | 5.5M | 2.8M | - | |
| 201501/10/2014 – 30/09/2015 | 3.2M | 2.5M | 5.3M | 3.1M | - | |
| 201401/10/2013 – 30/09/2014 | 3.7M | 3.1M | 6.6M | 3.6M | - | |
| 201301/10/2012 – 30/09/2013 | 2.9M | 2.4M | 5.7M | 3M | - | |
| 201201/10/2011 – 30/09/2012 | 3M | 2.2M | 10.2M | 7.6M | - |
Compared to 405 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of OBA-PHARMA ApS is 19995607.
OBA-PHARMA ApS is owned by LEV-VEL ApS and NLDB Holding ApS.
The management of OBA-PHARMA ApS consists of Malene Dybdahl Birch.
In 2026, OBA-PHARMA ApS reported a gross profit of DKK 1,434,475.
OBA-PHARMA ApS had 0 employees in 2000 according to the Danish CVR register.
OBA-PHARMA ApS was founded on 1 April 1997.
Claim this page to add your logo and social links. Free to get started.
OBA-PHARMA ApS has published its annual report for 2026. Gross profit came to DKK 1,434,475, and the net result was DKK 974,825.
Contact info changed: new phone: 33326647 (October 2, 2026).
As of September 30, 2026, BHA STATSAUTORISERET REVISION APS has stepped down as auditor of OBA-PHARMA ApS.
Address changed to Sølvgade 23 st., 1307 København K (April 9, 2026).
Contact info changed: new phone: 33326647 (April 9, 2026).
Address changed to Sølvgade 23 kl., 1307 København K (April 7, 2026).
Contact info changed: new phone: 33326647 (April 7, 2026).
OBA-PHARMA ApS has published its interim report for the period October 1, 2024 to June 30, 2025.
OBA-PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 3,402,201, and the net result was DKK 2,670,973.
As of June 27, 2024, Malene Dybdahl Birch is registered as director of OBA-PHARMA ApS.
As of June 27, 2024, Ole Birch has stepped down as director of OBA-PHARMA ApS.
As of June 27, 2024, LEV-VEL ApS is registered as an owner of OBA-PHARMA ApS with an ownership share of 50%.
As of June 27, 2024, NLDB Holding ApS is registered as an owner of OBA-PHARMA ApS with an ownership share of 50%.
OBA-PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 2,852,775, and the net result was DKK 2,073,440.
OBA-PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 1,041,316, and the net result was DKK 752,443.
OBA-PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 1,333,640, and the net result was DKK 1,001,773.
OBA-PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 1,119,532, and the net result was DKK 865,029.
OBA-PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 2,252,532, and the net result was DKK 1,803,661.
OBA-PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 2,521,605, and the net result was DKK 2,069,878.
OBA-PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 2,770,857, and the net result was DKK 2,155,159.
OBA-PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 2,809,440, and the net result was DKK 2,206,997.
As of February 3, 2017, BHA STATSAUTORISERET REVISION APS has been appointed auditor of OBA-PHARMA ApS.
OBA-PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 3,225,695, and the net result was DKK 2,490,654.
OBA-PHARMA ApS has published its annual report for 2014. Gross profit came to DKK 3,664,804, and the net result was DKK 3,119,719.
OBA-PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 2,900,864, and the net result was DKK 2,356,113.
OBA-PHARMA ApS has published its annual report for 2012. Gross profit came to DKK 2,970,531, and the net result was DKK 2,212,524.
As of November 19, 1999, Kurt Madsen has stepped down as auditor of OBA-PHARMA ApS.
On July 29, 1997, the company changed its name from PBH 25.376 ApS to OBA-PHARMA ApS.
As of July 28, 1997, Kurt Madsen has been appointed auditor of OBA-PHARMA ApS.
As of July 28, 1997, Harry Aamann has stepped down as auditor of OBA-PHARMA ApS.
As of July 28, 1997, Ole Birch is registered as director of OBA-PHARMA ApS.
As of July 28, 1997, Preben Bang Henriksen has stepped down as director of OBA-PHARMA ApS.
As of April 1, 1997, Harry Aamann has been appointed auditor of OBA-PHARMA ApS.
As of April 1, 1997, Preben Bang Henriksen is registered as director of OBA-PHARMA ApS.
OBA-PHARMA ApS was founded on April 1, 1997.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 19064301
CVR 37726508
CVR 19835081
CVR 21327581
CVR 46124723
